Skip to content

Using Immersive Virtual Reality to Treat Pediatric Anxiety

Virtually Better: Using Immersive Virtual Reality to Treat Pediatric Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04504773
Enrollment
3
Registered
2020-08-07
Start date
2020-09-17
Completion date
2023-02-14
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Anxiety Disorder, Specific Phobia, Specific Phobia, Animal, Specific Phobia, Natural Environment, Specific Phobia, Situational

Keywords

Exposure Therapy, Virtual Reality

Brief summary

Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called exposures. While exposures are effective, some feared situations cannot be confronted in a clinician's office (e.g., heights, public speaking, storms). This poses a logistical challenge in treatment that: (1) takes time away from patient care, (2) leads clinicians to rely on imagined exposures, and/or (3) requires families to complete exposures outside of the therapy visits. This creates a burden for clinicians and families, and impedes treatment success. Immersive virtual reality (VR) presents an innovative solution that allows children to face fears without leaving the clinician's office. While VR has been used to distract children during painful medical procedures, it has not been well examined as a primary treatment for pediatric anxiety. This study proposes to examine the effectiveness and acceptability of using immersive VR exposures to treat children and adolescents with specific phobias.

Interventions

BEHAVIORALVirtual Reality Exposure Therapy

Participants will receive a single session of virtual reality exposure therapy that targets the participant's specific phobia stimuli.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Outcomes assessor is not involved in treatment, and will assess the severity of the participants anxiety.

Eligibility

Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* 8-17 years (inclusive), * meet diagnostic criteria for one or more phobias on a structured diagnostic interview (ADIS-C/P). This specifically includes natural environments (e.g., storms, heights) and/or situational settings (e.g., airplanes, public speaking). * be fluent in English.

Exclusion criteria

* unable to complete rating scales, or * attend study visits.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Severity Rating (CSR) of Targeted Specific Phobia on Anxiety Disorder Interview Schedule for Children and Parents (ADIS-C/P)1 week after virtual reality exposure therapy sessionThe ADIS-C/P CSR for the Specific Phobia is a single item rating that is made by a clinician. Scores are made on a 9-point scale that ranges from 0 (Not at all) to 8 (Very, very much). A score of 4 or greater considered to be indicative of a psychiatric disorder.

Secondary

MeasureTime frameDescription
Screen for Childhood Anxiety and Related Disorders-Parent Report (SCARED-P)1 week after virtual reality exposure therapy sessionParent-reported rating of child anxiety that consists of 41-items. Items are rated on a 3-point scale that ranges from 0 (Not True) to 2 (Very True). The total score ranges from 0 to 82, with a total score of 25 or greater may indicate the presence of an anxiety disorder.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026